Clinical Trials Browser

OTHER × Breast Neoplasm Female × Trastuzumab × Clear all

NCT05577442 2022-10-19

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasm Female